Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01433627
Recruitment Status : Unknown
Verified January 2015 by Italian Society of Invasive Cardiology.
Recruitment status was:  Active, not recruiting
First Posted : September 14, 2011
Last Update Posted : January 29, 2015
Sponsor:
Collaborator:
Eustrategy
Information provided by (Responsible Party):
Italian Society of Invasive Cardiology

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Actual Primary Completion Date : November 2014
Estimated Study Completion Date : December 2015
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):